NORDITROPIN NORDILET 30IU PEN ( novo nordisk )* 10mg/1.5ml
Norditropin Nordilet 10mg (30IU) delivery pens are the only prefilled, multi-dose, disposable growth hormone pens that, after initial use, can be stored at up to 77°F for use within 3 weeks Unlike other growth hormone delivery pens.
Who should not use Norditropin? Do not use Norditropin if: you have a critical illness caused by certain types of heart or stomach surgery, trauma or breathing (respiratory) problems; you are a child with Prader-Willi syndrome who is severely obese or has breathing problems including sleep apnea
Norditropin Nordilet is prefilled and premixed. This means you don’t have to load the growth hormone with cartridges Users of Norditropin Nordilet have access to NordiCare® patient support, which can help you with Norditropin Nordilet insurance issues you may have Norditropin Nordilet offers multiple doses which means most patients can use the pen several times before the medicine runs out.
Uses and dosage :
Norditropin Nordilet 10mg/1.5ml (30IU) is a pre-filled pen, which is designed to be used with NovoFine needles. The dose is delivered in clicks. hgh Norditropin Nordilet delivers 1 to 29 clicks in increments of 1 click for each injection. The dose per click is 0.1333mg (10mg/1.5ml). In the package leaflet for each strength a range of doses in mg per number of clicks is given in a conversion table. The dosage is individual. Generally, daily subcutaneous injection in the evening is recommended. The injection site should be varied to prevent lipoatrophy. Prescription only. For the injection procedure, please
see the instruction manual for hgh Norditropin Nordilet 10mg/1.5ml.Patients should be reminded to wash their hands thoroughly with soap and water and/or disinfectant
prior to any contact with Norditropin NordiLet. Norditropin NordiLet should not be shaken vigorously at any time. General recommendations for dosages are shown
Growth hormone insufficiency:
25 to 35 microgram/kg/day or 0.7 to 1.0mg/m²/day In children with Turner syndrome: 45 to 67 microgram/kg/day or 1.3 to 2.0mg/m²/day In children with Chronic renal disease: 50 microgram/kg/day or 1.4mg/m²/day In children born small for gestational age (SGA): 33 to 67 microgram/kg/day or 1.0 to 2.0mg/m²/day
Replacement therapy: It is recommended to start treatment with a low dose 0.1–0.3mg/day and to increase the dosage gradually at monthly intervals in order to meet the need of the individual patient. Serum IGF–I can be used as guidance for the dose titration. Dose requirementsdecline with age. Maintenance dosages vary from person to person, but seldom exceed 1.0mg/day (equal to 3 IU/day).
serious allergic reactions. Get medical help right away if you have the following symptoms: swelling of your face, lips, mouth or tongue, trouble breathing, wheezing, severe itching, skin rashes, redness or swelling, dizziness or fainting, fast heartbeat or pounding in your chest, or sweating.
decrease in hormone called cortisol
decrease in thyroid hormone levels.
hip and knee pain or a limp in children (slipped capital femoral epiphysis).
worsening of pre-existing curvature of the spine (scoliosis).
middle ear infection, hearing or ear problems in patients with Turner syndrome.
redness, itching and tissue weakness in the area of skin you inject.
increase in phosphorus, alkaline phosphatase, and parathyroid hormone levels in your blood.
The most common side effects of Norditropin include:
headaches, muscle pain, joint stiffness, high blood sugar (hyperglycemia), and sugar in your urine (glucosuria).